Visual Communication: Digital Tool to Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and Providers

Launched by NYU LANGONE HEALTH · Apr 8, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a new digital tool designed to help patients with cancer better understand their treatment options and improve their overall experience during their care. The study will include patients who have recently been diagnosed with breast or head and neck cancer and are receiving treatment at NYU Langone Health. Both patients and their caregivers will be part of the research, along with medical professionals who provide their care. The goal is to see if the use of this visual communication tool makes patients and caregivers feel more satisfied with the information they receive and their overall experience.

To be eligible for this trial, participants must be between 18 and 100 years old, English-speaking, and be diagnosed with one of the specified types of cancer. Caregivers of these patients can also participate if they are adults and can provide consent. The trial is not yet recruiting participants, but once it begins, those involved can expect to engage with the visual tool and share their feedback through surveys about their experience. It’s important to note that the tool is currently only available in English, but efforts are being made to translate it into other languages.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Patients:
• • Patients seen in consultation from 12/1/2024-6/1/2025
• • Patients aged 18 years to 100 years old
• • Patients with a malignancy of breast or head and neck
• • English speaking patients
• • Patients being treated with definitive intent
• • Patients treated at NYU Langone Health for their malignancy
• • Willing and able to provide consent
• Caregivers:
• • Any adult caregiver(s) (aged 18 years to 100 years old) to a patient who fulfills the inclusion and exclusion criteria above.
• • Willing and able to provide consent
• Providers:
• • Doctors and nurse practitioners in medical oncology and radiation oncology, and in the ear nose throat (ENT) department.
• • Willing and able to provide consent
• • aged 18 years to 100 years old
• Exclusion Criteria:
• Patients:
• • Patients with any other site of disease other than listed above
• • Non-English-speaking patients, as the tool is currently available in English only. Translation into additional languages such as Spanish and Russian is currently in process.
• • Patient unable to complete the survey portion of the study independently
• Caregivers:
• • • Unable to complete the survey portion of the study independently